HC Wainwright Trims Tango Therapeutics (NASDAQ:TNGX) Target Price to $13.00

Tango Therapeutics (NASDAQ:TNGX – Free Report) had its price target trimmed by HC Wainwright from $16.00 to $13.00 in a report released on Tuesday morning, Benzinga reports. The brokerage currently has a buy rating on the stock. HC Wainwright also issued estimates for Tango Therapeutics’ Q2 2024 earnings at ($0.36) EPS, Q3 2024 earnings at […]

Related Keywords

China ,Piper Sandler ,Cantor Fitzgerald ,Paloma Partners Management Co ,Barclays ,China Universal Asset Management Co ,Mva Investors Llc ,Tango Therapeutics Inc ,Pricet Rowe Associates Inc ,Tango Therapeutics ,Free Report ,Get Free Report ,Mva Investors ,Universal Asset Management ,Pricet Rowe Associates ,Tango Therapeutics Daily ,